(marketscreener.com) Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed sale of Flexion Therapeutics, Inc. to Pacira BioSciences, Inc. . Under the terms of the proposed transaction, shareholders of Flexion will receive only $8.50 in cash and one non-tradable contingent value...https://www.marketscreener.com/quote/stock/FLEXION-THERAPEUTICS-INC-15749853/news/FLEXION-THERAPEUTICS-INVESTOR-ALERT-by-the-Former-Attorney-General-of-Louisiana-Kahn-Swick-Foti-36663206/?utm_medium=RSS&utm_content=20211012